IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ascendis Pharma A/S

CUSIP: BV9G6B8US | 1 institutional holders

Quarters

Q2 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2019

Knott David M656
0.0% of portfolio›$76
StyleTurnoverLocationFiled
Knott David M
656$760.0%N/AN/ASyosset, NY2019-08-12